(Q95601484)

https://api.crossref.org/v1/works/http://dx.doi.org/10.1101/2020.05.10.087288

27 May 2020

preprint

0 references

title

SARS-CoV-2 spike protein binds heparan sulfate in a length- and sequence-dependent manner (English)

1 reference

https://api.crossref.org/v1/works/http://dx.doi.org/10.1101/2020.05.10.087288

27 May 2020

1 reference

spike glycoprotein [SARS-CoV-2]

1 reference

based on heuristic

inferred from abstract

author

Lin Liu

1

2 references

https://api.crossref.org/v1/works/http://dx.doi.org/10.1101/2020.05.10.087288

27 May 2020

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32511404%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

Pradeep Chopra

2

2 references

https://api.crossref.org/v1/works/http://dx.doi.org/10.1101/2020.05.10.087288

27 May 2020

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32511404%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

Margreet A Wolfert

4

2 references

https://api.crossref.org/v1/works/http://dx.doi.org/10.1101/2020.05.10.087288

27 May 2020

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32511404%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

Stephen M Tompkins

5

2 references

https://api.crossref.org/v1/works/http://dx.doi.org/10.1101/2020.05.10.087288

27 May 2020

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32511404%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

Geert-Jan Boons

6

2 references

https://api.crossref.org/v1/works/http://dx.doi.org/10.1101/2020.05.10.087288

27 May 2020

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32511404%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

author name string

Xiuru Li

3

2 references

https://api.crossref.org/v1/works/http://dx.doi.org/10.1101/2020.05.10.087288

27 May 2020

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32511404%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

publication date

11 May 2020

1 reference

https://api.crossref.org/v1/works/http://dx.doi.org/10.1101/2020.05.10.087288

Virus entry: molecular mechanisms and biomedical applications

27 May 2020

cites work

1 reference

https://api.crossref.org/works/10.1101/2020.05.10.087288

Structure of SARS coronavirus spike receptor-binding domain complexed with receptor

26 April 2021

1 reference

https://api.crossref.org/works/10.1101/2020.05.10.087288

Embracing the Landscape of Therapeutics

26 April 2021

1 reference

https://api.crossref.org/works/10.1101/2020.05.10.087288

Identification of sialic acid-binding function for the Middle East respiratory syndrome coronavirus spike glycoprotein.

26 April 2021

1 reference

https://api.crossref.org/works/10.1101/2020.05.10.087288

Human coronavirus NL63 utilizes heparan sulfate proteoglycans for attachment to target cells

26 April 2021

1 reference

https://api.crossref.org/works/10.1101/2020.05.10.087288

Inhibition of SARS pseudovirus cell entry by lactoferrin binding to heparan sulfate proteoglycans

26 April 2021

1 reference

https://api.crossref.org/works/10.1101/2020.05.10.087288

The 2019 coronavirus (SARS-CoV-2) surface protein (Spike) S1 Receptor Binding Domain undergoes conformational change upon heparin binding

26 April 2021

1 reference

https://api.crossref.org/works/10.1101/2020.05.10.087288

Glycosaminoglycan binding motif at S1/S2 proteolytic cleavage site on spike glycoprotein may facilitate novel coronavirus (SARS-CoV-2) host cell entry

26 April 2021

1 reference

https://api.crossref.org/works/10.1101/2020.05.10.087288

Coronavirus membrane fusion mechanism offers as a potential target for antiviral development

26 April 2021

1 reference

https://api.crossref.org/works/10.1101/2020.05.10.087288

Heparin inhibits cellular invasion by SARS-CoV-2: structural dependence of the interaction of the surface protein (spike) S1 receptor binding domain with heparin

26 April 2021

1 reference

https://api.crossref.org/works/10.1101/2020.05.10.087288

SARS-CoV-2 Infection Depends on Cellular Heparan Sulfate and ACE2

26 April 2021

1 reference

https://api.crossref.org/works/10.1101/2020.05.10.087288

Heparan sulphate proteoglycans fine-tune mammalian physiology

26 April 2021

1 reference

https://api.crossref.org/works/10.1101/2020.05.10.087288

Heparan Sulfate Proteoglycans and Viral Attachment: True Receptors or Adaptation Bias?

26 April 2021

1 reference

https://api.crossref.org/works/10.1101/2020.05.10.087288

Cleavage of group 1 coronavirus spike proteins: how furin cleavage is traded off against heparan sulfate binding upon cell culture adaptation

26 April 2021

1 reference

https://api.crossref.org/works/10.1101/2020.05.10.087288

Murine coronavirus with an extended host range uses heparan sulfate as an entry receptor

26 April 2021

1 reference

https://api.crossref.org/works/10.1101/2020.05.10.087288

Heparan sulfate proteoglycans

26 April 2021

1 reference

https://api.crossref.org/works/10.1101/2020.05.10.087288

Demystifying heparan sulfate-protein interactions.

26 April 2021

1 reference

https://api.crossref.org/works/10.1101/2020.05.10.087288

Glycosaminoglycans in infectious disease

26 April 2021

1 reference

https://api.crossref.org/works/10.1101/2020.05.10.087288

Surface Proteoglycans as Mediators in Bacterial Pathogens Infections

26 April 2021

1 reference

https://api.crossref.org/works/10.1101/2020.05.10.087288

Heparan Sulfate Microarray Reveals That Heparan Sulfate-Protein Binding Exhibits Different Ligand Requirements

26 April 2021

1 reference

https://api.crossref.org/works/10.1101/2020.05.10.087288

Modular synthesis of heparan sulfate oligosaccharides for structure-activity relationship studies.

26 April 2021

1 reference

https://api.crossref.org/works/10.1101/2020.05.10.087288

SARS-CoV-2 Seroconversion in Humans: A Detailed Protocol for a Serological Assay, Antigen Production, and Test Setup

26 April 2021

1 reference

https://api.crossref.org/works/10.1101/2020.05.10.087288

A serological assay to detect SARS-CoV-2 seroconversion in humans

26 April 2021

1 reference

https://api.crossref.org/works/10.1101/2020.05.10.087288

Characterization of heparin and severe acute respiratory syndrome-related coronavirus 2 (SARS-CoV-2) spike glycoprotein binding interactions

26 April 2021

1 reference

https://api.crossref.org/works/10.1101/2020.05.10.087288

Structural basis of receptor recognition by SARS-CoV-2

26 April 2021

1 reference

https://api.crossref.org/works/10.1101/2020.05.10.087288

The role of furin cleavage site in SARS-CoV-2 spike protein-mediated membrane fusion in the presence or absence of trypsin

26 April 2021

1 reference

https://api.crossref.org/works/10.1101/2020.05.10.087288

Infection and Rapid Transmission of SARS-CoV-2 in Ferrets

26 April 2021

1 reference

https://api.crossref.org/works/10.1101/2020.05.10.087288

SARS-CoV-2 is transmitted via contact and via the air between ferrets

26 April 2021

1 reference

https://api.crossref.org/works/10.1101/2020.05.10.087288

Heparin and heparan sulfate: structure and function

26 April 2021

1 reference

https://api.crossref.org/works/10.1101/2020.05.10.087288

The heparan sulfate motif (GlcNS6S-IdoA2S)3, common in heparin, has a strict topography and is involved in cell behavior and disease.

26 April 2021

1 reference

https://api.crossref.org/works/10.1101/2020.05.10.087288

Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy

26 April 2021

1 reference

https://api.crossref.org/works/10.1101/2020.05.10.087288

ISTH interim guidance on recognition and management of coagulopathy in COVID-19

26 April 2021

1 reference

https://api.crossref.org/works/10.1101/2020.05.10.087288

Heparan sulfate 3-O-sulfation: a rare modification in search of a function.

26 April 2021

1 reference

https://api.crossref.org/works/10.1101/2020.05.10.087288

ACE2-independent interaction of SARS-CoV-2 spike protein to human epithelial cells can be inhibited by unfractionated heparin

26 April 2021

0 references

Multimerization- and glycosylation-dependent receptor binding of SARS-CoV-2 spike proteins

0 references

Is COVID-19 an Endothelial Disease? Clinical and Basic Evidence

0 references

Identifiers

2 references

https://api.crossref.org/v1/works/http://dx.doi.org/10.1101/2020.05.10.087288

27 May 2020

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32511404%20AND%20SRC:MED&resulttype=core&format=json

Dimensions Publication ID

12 June 2020

1127503867

1 reference

Dimensions COVID-19 publications, datasets and clinical trials

10.6084/M9.FIGSHARE.11961063

28 May 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32511404%20AND%20SRC:MED&resulttype=core&format=json